Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000587448 | SCV000696053 | uncertain significance | not provided | 2016-04-08 | criteria provided, single submitter | clinical testing | Variant summary: The c.1622T>C Variant affects a non-conserved nucleotide and results in a replacement of a medium size and hydrophobic Valine (V) with a small size and hydrophobic Alanine (A). 2/4 in silico tools predict the variant to be neutral. The variant is absent from the large and broad cohorts of the ExAC project and to our knowledge, it has not been reported in affected patients either. Due to the lack of clinical data and functional studies, the variant was classified as a variant of uncertain significance until more information becomes available. |
Fulgent Genetics, |
RCV002476273 | SCV002778125 | uncertain significance | Familial Mediterranean fever; Familial Mediterranean fever, autosomal dominant; Acute febrile neutrophilic dermatosis | 2022-01-19 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001829616 | SCV003802076 | uncertain significance | Familial Mediterranean fever | 2023-02-08 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003126832 | SCV003802077 | likely benign | Familial Mediterranean fever, autosomal dominant | 2023-02-08 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003126833 | SCV003802079 | likely benign | Acute febrile neutrophilic dermatosis | 2023-02-08 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001829616 | SCV002087394 | uncertain significance | Familial Mediterranean fever | 2021-06-03 | no assertion criteria provided | clinical testing |